1. Pharmacogenetic explanation for excessive beta-blockage following timolol eye drops. Potential for oral ophthalmic drug interaction;Edeki;JAMA,1995
2. The control of drug bioavailability from ophthalmic dosage forms;Schoenwald,1985
3. Pharmacokinetics of topically applied ophthalmic drugs;Shell;Surv Ophthalmol,1982
4. Determination of tear volume and tear flow;Mishima;Invest Ophthalmol,1966
5. Factors influencing the retention of ophthalmic solutions on the eye surface;Van Ootegham,1987